Tipranavir

Results: 69



#Item
41APTIVUS (tipranavir) Label

APTIVUS (tipranavir) Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-04-06 12:38:40
42

PDF Document

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-01-24 19:47:26
43HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NORVIR safely and effectively. See full prescribing information for NORVIR. NORVIR (ritonavir) Tablet for Oral use N

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NORVIR safely and effectively. See full prescribing information for NORVIR. NORVIR (ritonavir) Tablet for Oral use N

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-11-26 16:16:36
44HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUSĀ® (tipranavir) capsules APTIVU

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use APTIVUS safely and effectively. See full prescribing information for APTIVUS. APTIVUSĀ® (tipranavir) capsules APTIVU

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-04-08 13:54:36
45Food and Drug Administration

Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-05-25 15:51:21
46Protease inhibitors / Medicinal chemistry / Pyridines / Food and Drug Administration / United States Department of Health and Human Services / Tipranavir / Boehringer Ingelheim / Pharmaceutical drug / Center for Drug Evaluation and Research / Pharmacology / Pharmaceutical sciences / Clinical research

Food and Drug Administration Center for Drug Evaluation and Research (CDER) Antiviral Drugs Advisory Committee May 19, 2005

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-05-25 15:51:21
47Pharmaceutical sciences / Clinical research / Design of experiments / Carbamates / Food and Drug Administration / Tipranavir / Ritonavir / Clinical trial / Chemistry / Protease inhibitors / Pharmacology

Food and Drug Administration Center for Drug Evaluation and Research SUMMARY MINUTES OF THE CDER ANTIVIRAL DRUGS ADVISORY COMMITTEE

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-06-20 14:31:16
48Food and Drug Administration

Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-05-25 15:52:57
49[removed]violation. Patients could have one, two, three or

[removed]violation. Patients could have one, two, three or

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-07-08 15:14:01
50301 1 fully work up all those suspected of liver disease.  2

301 1 fully work up all those suspected of liver disease. 2

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-07-08 15:14:02